Coya Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
212
across all filing types
Latest filing
2026-05-13
Annual Report
Country
US
United States of America
Listing
US
COYA
Coya Therapeutics, Inc. is a clinical-stage biotechnology company that develops proprietary biologics and multi-modality therapies designed to enhance the function of regulatory T cells (Tregs). The company's approach focuses on modulating dysfunctional Tregs to suppress inflammation associated with neurodegenerative, autoimmune, and metabolic diseases. Its lead product candidate, COYA 302, is an investigational biologic combination therapy being evaluated for the treatment of Amyotrophic Lateral Sclerosis (ALS). The pipeline also includes other candidates such as COYA 303, a combination of low-dose Interleukin-2 (IL-2) and a GLP-1 receptor agonist, intended for inflammation-driven diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-05-13 | English | |
| DEF 14A - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-05-13 | English | |
| 8-K - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-05-12 | English | |
| 424B5 - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-05-12 | English | |
| 10-Q - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-05-12 | English | |
| 8-K - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-05-12 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45589489 | ARS - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-05-13 | English | ||
| 45588995 | DEF 14A - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-05-13 | English | ||
| 45268238 | 8-K - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-05-12 | English | ||
| 45266702 | 424B5 - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-05-12 | English | ||
| 45246121 | 10-Q - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-05-12 | English | ||
| 45244496 | 8-K - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-05-12 | English | ||
| 33157224 | 8-K - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-04-02 | English | ||
| 33012250 | EFFECT - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-03-23 | English | ||
| 31987353 | 8-K Filing | 2026-01-30 | English | ||
| 31987344 | SCHEDULE 13G/A Filing | 2026-01-30 | English | ||
| 31987320 | SCHEDULE 13G/A Filing | 2026-01-28 | English | ||
| 13347572 | 4 | 2026-01-26 | English | ||
| 13347573 | 4 | 2026-01-26 | English | ||
| 13347576 | 4 | 2026-01-26 | English | ||
| 13347577 | 4 | 2026-01-26 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adlai Nortye Ltd.
A clinical-stage biopharma firm developing cancer immunothe…
|
ANL | KY | Manufacturing |
|
ADLINE CHEM LAB LIMITED
Produces APIs, chemical intermediates, and specialty chemic…
|
524604 | IN | Manufacturing |
|
ADMA BIOLOGICS, INC.
Biopharmaceutical company that develops and manufactures pl…
|
ADMA | US | Manufacturing |
|
Advectus Life Sciences Inc.
Advances drug delivery systems using proprietary nanopartic…
|
AVXSF | CA | Manufacturing |
|
Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocul…
|
ADVM | US | Manufacturing |
|
Advicenne
A specialty pharmaceutical company developing treatments fo…
|
ALDVI | FR | Manufacturing |
|
AegirBio AB
A diagnostics company specializing in therapeutic drug moni…
|
AEGIR | SE | Manufacturing |
|
Aelis Farma
Biopharmaceutical company developing CB1 receptor inhibitor…
|
AELIS | FR | Manufacturing |
|
AEON Biopharma, Inc.
Clinical-stage company developing therapeutic applications …
|
AEON | US | Manufacturing |
|
Aequus Pharmaceuticals Inc.
Developing and commercializing specialty pharmaceutical pro…
|
AQS | CA | Manufacturing |
Coya Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34219/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34219 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34219 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34219 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34219}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Coya Therapeutics, Inc. (id: 34219)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.